BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gauba K, Gupta S, Shekhawat J, Sharma P, Yadav D, Banerjee M. Immunomodulation by epigenome alterations in Mycobacterium tuberculosis infection. Tuberculosis (Edinb) 2021;128:102077. [PMID: 33812175 DOI: 10.1016/j.tube.2021.102077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Behura A, Das M, Kumar A, Naik L, Mishra A, Manna D, Patel S, Mishra A, Singh R, Dhiman R. ESAT-6 impedes IL-18 mediated phagosome lysosome fusion via microRNA-30a upon Calcimycin treatment in mycobacteria infected macrophages. Int Immunopharmacol 2021;101:108319. [PMID: 34740079 DOI: 10.1016/j.intimp.2021.108319] [Reference Citation Analysis]
2 Merchant SA, Shaikh MJS, Nadkarni P. Tuberculosis conundrum - current and future scenarios: A proposed comprehensive approach combining laboratory, imaging, and computing advances. World J Radiol 2022; 14(6): 114-136 [DOI: 10.4329/wjr.v14.i6.114] [Reference Citation Analysis]
3 Sui J, Qiao W, Xiang X, Luo Y. Epigenetic Changes in Mycobacterium tuberculosis and its Host Provide Potential Targets or Biomarkers for Drug Discovery and Clinical Diagnosis. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106195] [Reference Citation Analysis]
4 Madden K, Liang YC, Rajabalee N, Alvarez GG, Sun J. Surveying the Epigenetic Landscape of Tuberculosis in Alveolar Macrophages. Infect Immun 2022;:e0052221. [PMID: 35311579 DOI: 10.1128/iai.00522-21] [Reference Citation Analysis]